VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 02/05/2025 at 07:00, 1 year ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year 2 months ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year 2 months ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 1 year 2 months ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 1 year 2 months ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year 2 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 1 year 2 months ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
PRESS RELEASE

published on 11/26/2024 at 17:45, 1 year 2 months ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data

FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF

published on 10/10/2024 at 07:05, 1 year 3 months ago

Valneva presents its outlook at an investor day in New York

Investors Growth Valneva Vaccines Lyme
PRESS RELEASE

published on 10/10/2024 at 07:00, 1 year 3 months ago

Valneva Hosts Investor Day in New York City
Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions

Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines

Accesswire

Published on 02/07/2026 at 01:00, 1 day 12 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 14 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 15 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 21 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 23 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 16 hours 15 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 20 hours 40 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 20 hours 55 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 17 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 19 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 18 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 21 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 17 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 18 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 19 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE